IP Library › Assignment 027675/0229
Patent Assignment
Reel/Frame 027675/0229

Assignment of Assignor's Interest

Recorded: 2012-02-08 Pages: 39
Assignors
GREENSMITH, LINDA
Executed: 2003-11-03
BURNSTOCK, GEOFFREY
Executed: 2003-10-29
Assignee
BIOREX RESEARCH AND DEVELOPMENT COMPANY RT (VA)
8200 VESZPRE, SZABADSAGPUSZTA, HUNGARY
Covered Properties (2)
Use Of A Hydroximic Acid Halide Derivative In The Treatment Of Neurodegenerative Diseases
Application: 10/582,124 →
Publication: US 2008/0039497
Use of a Hydroximic Acid Halide Derivative in the Treatment of Neurodegenerative Diseases
Patent: 8,962,604 →
Application: 13/229,862 →
Publication: US 2012/0115908
Related Assignments (13)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 8, 2012
From: BIOREX KUTATO ES FEJLESZTO RT (VA); BRX RESEARCH AND DEVELOPMENT COMPANY LTD.
To: CYTRX CORPORATION
Reel/Frame 027671/0697 →
Assignment of Assignor's Interest Feb 8, 2012
From: URBANICS, RUDOLF
To: CYTRX CORPORATION
Reel/Frame 027671/0717 →
Assignment of Assignor's Interest Feb 8, 2012
From: CYTRX CORPORATION
To: ORPHAZYME APS
Reel/Frame 027671/0739 →
Corrective Assignment to Correct the Application Serial Number 13/299862 Previously Recorded on Reel 027671 Frame 0697. Assignor(S) Hereby Confirms the Correct Serial Number 13/229862. Feb 9, 2012
From: BIOREX KUTATO ES FEJLESZTO RT (VA); BRX RESEARCH AND DEVELOPMENT COMPANY LTD.
To: CYTRX CORPORATION
Reel/Frame 027682/0713 →
Corrective Assignment to Correct the Application Serial Number 13/299862 Previously Recorded on Reel 027675 Frame 0229. Assignor(S) Hereby Confirms the Correct Serial Number 13/229862. Feb 13, 2012
From: GREENSMITH, LINDA; BURNSTOCK, GEOFFREY
To: BIOREX RESEARCH AND DEVELOPMENT COMPANY RT (VA)
Reel/Frame 027691/0525 →
Change of Name Apr 11, 2018
From: ORPHAZYME APS
To: ORPHAZYME A/S
Reel/Frame 045911/0992 →
Security Interest Sep 6, 2019
From: ORPHAZYME A/S; ORPHAZYME US, INC.
To: KREOS CAPITAL VI (UK) LIMITED
Reel/Frame 050294/0026 →
Assignment of Assignor's Interest Jul 6, 2022
From: ORPHAZYME A/S
To: KEMPHARM, INC.
Reel/Frame 060592/0646 →
Assignment of Assignor's Interest Jul 6, 2022
From: KEMPHARM, INC.
To: KEMPHARM DENMARK A/S
Reel/Frame 060592/0595 →
Assignment of Assignor's Interest Jul 7, 2022
From: ORPHAZYME A/S
To: KEMPHARM, INC.
Reel/Frame 060430/0942 →
Assignment of Assignor's Interest Jul 7, 2022
From: KEMPHARM, INC.
To: KEMPHARM DENMARK A/S
Reel/Frame 060430/0835 →
Change of Name Oct 12, 2022
From: ORPHAZYME APS
To: ORPHAZYME A/S
Reel/Frame 061663/0293 →
Release of Security Interest Apr 4, 2024
From: KREOS CAPITAL VI (UK) LIMITED
To: ZEVRA DENMARK A/S (F/K/A KEMPHARM DENMARK A/S, SUCCESSOR IN INTEREST TO ORPHAZYME A/S)
Reel/Frame 067007/0706 →